Synonyms: [3-glutamic acid(D>E)]human uroguanylin | SP-304 | Trulance®
plecanatide is an approved drug (FDA (2017))
Compound class:
Peptide
Comment: Plecanatide is a synthetic analogue of uroguanylin, which is an agonist of the guanylate cyclase C (GC-C) receptor (GUCY2C) [3]. Activation of GC-C in mucosal epithelial cells of the gastrointestinal (GI) tract causes the secretion of fluid, facilitating bowel movements. Plecanatide has potential to help manage constipating GI disorders, such as chronic idiopathic constipation and constipation-predominant irritable bowel syndrome (IBS-C). Plecanatide is one of the peptides claimed in patent WO2014151206, where it is represented by SEQ ID NO: 1 and code SP-304, with residue 3 (Aad) being gultamic acid (E, Glu) [2].
The SMILES and structure image used in this entry are from Chemicalize. HELM notation is PEPTIDE1{N.D.E.C.E.L.C.V.N.V.A.C.T.G.C.L}$PEPTIDE1,PEPTIDE1,12:R3-4:R3|PEPTIDE1,PEPTIDE1,15:R3-7:R3$$$. linaclotide was the first GC-C activator to reach the clinic, like plecanatide it is approved for the treatment of chronic constipation and IBS-C. |
Classification | |
Compound class | Peptide |
Approved drug? | Yes (FDA (2017)) |
International Nonproprietary Names | |
INN number | INN |
9367 | plecanatide |
Synonyms |
[3-glutamic acid(D>E)]human uroguanylin | SP-304 | Trulance® |
Database Links | |
ChEMBL Ligand | CHEMBL2103867 |
DrugCentral Ligand | 5208 |
GtoPdb PubChem SID | 315661154 |
PubChem CID | 70693500 |
Search Google for chemical match using the InChIKey | NSPHQWLKCGGCQR-DLJDZFDSSA-N |
Search Google for chemicals with the same backbone | NSPHQWLKCGGCQR |
Search PubMed clinical trials | plecanatide |
Search PubMed titles | plecanatide |
Search PubMed titles/abstracts | plecanatide |
UniChem Compound Search for chemical match using the InChIKey | NSPHQWLKCGGCQR-DLJDZFDSSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | NSPHQWLKCGGCQR-DLJDZFDSSA-N |